Stopping Immunomodulatory Therapies
WebcastFaculty
OVERVIEW
Stopping Immunomodulatory Therapies is organized by Vindico Medical Education and will be held during Aug 16, 2016 - Aug 15, 2018.
The target audience for this medical event is neurologists and other health care professionals involved in the treatment of patients with MS. This CME Conference has been approved for a maximum of 0.5 AMA PRA Category 1 Credits.
Conference Objectives are :
Upon successful completion of this educational activity, participants should be better able to:
• Evaluate the benefits and limitations of available oral agents for the treatment of relapsing-remitting MS (RRMS). • Review the clinical efficacy and safety of emerging oral therapies for the management of RRMS.
Additional details will be posted as soon as they are available.
The target audience for this medical event is neurologists and other health care professionals involved in the treatment of patients with MS. This CME Conference has been approved for a maximum of 0.5 AMA PRA Category 1 Credits.
Conference Objectives are :
Upon successful completion of this educational activity, participants should be better able to:
• Evaluate the benefits and limitations of available oral agents for the treatment of relapsing-remitting MS (RRMS). • Review the clinical efficacy and safety of emerging oral therapies for the management of RRMS.
Additional details will be posted as soon as they are available.
SPECIALITIES
ImmunotherapiesQuick Links